Vanguard Group’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-449,061
| Closed | -$203K | – | 4185 |
|
|
2016
Q2 | $203K | Hold |
449,061
| – | – | ﹤0.01% | 3950 |
|
|
2016
Q1 | $1.21M | Buy |
449,061
+14,917
| +3% | +$40.1K | ﹤0.01% | 3543 |
|
|
2015
Q4 | $1.34M | Buy |
434,144
+4,797
| +1% | +$14.8K | ﹤0.01% | 3536 |
|
|
2015
Q3 | $1.9M | Buy |
429,347
+63,939
| +17% | +$283K | ﹤0.01% | 3404 |
|
|
2015
Q2 | $2.09M | Buy |
365,408
+35,988
| +11% | +$205K | ﹤0.01% | 3402 |
|
|
2015
Q1 | $2.95M | Buy |
329,420
+248,012
| +305% | +$2.22M | ﹤0.01% | 3245 |
|
|
2014
Q4 | $461K | Buy |
81,408
+19,763
| +32% | +$112K | ﹤0.01% | 3758 |
|
|
2014
Q3 | $444K | Buy |
+61,645
| New | +$444K | ﹤0.01% | 3747 |
|